Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-14-004411
Filing Date
2014-08-14
Accepted
2014-08-14 15:10:49
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q biei_10q.htm 10-Q 1129142
2 CERTIFICATION biei_ex311.htm EX-31.1 15687
3 CERTIFICATION biei_ex312.htm EX-31.2 16117
4 CERTIFICATION biei_ex321.htm EX-32.1 6268
5 CERTIFICATION biei_ex322.htm EX-32.2 6435
  Complete submission text file 0001477932-14-004411.txt   4613898

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT biei-20140630.xml EX-101.INS 604149
7 XBRL TAXONOMY EXTENSION SCHEMA biei-20140630.xsd EX-101.SCH 50477
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE biei-20140630_cal.xml EX-101.CAL 36681
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE biei-20140630_def.xml EX-101.DEF 99759
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE biei-20140630_lab.xml EX-101.LAB 267149
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE biei-20140630_pre.xml EX-101.PRE 177694
Mailing Address P.O. BOX 31374 EL PASO TX 79930
Business Address P.O. BOX 31374 EL PASO TX 79930 814 786 8849
PREMIER BIOMEDICAL INC (Filer) CIK: 0001515740 (see all company filings)

EIN.: 272635666 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54563 | Film No.: 141042094
SIC: 2836 Biological Products, (No Diagnostic Substances)